Keywords: introgen, therapeutics, gets, million, milestone, payment, r-pr

Introgen Therapeutics Gets $5 Million Milestone Payment From R-PR

Article | 17 February 1997

Rhone-Poulenc Rorer has made a $5 million milestone payment to USgene-based cancer therapeutics firm Introgen Therapeutics. The milestone was triggered for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in